We are live on ! Find out more
CAPR icon

Capricor Therapeutics
CAPR

18 hedge funds and large institutions have $677K invested in Capricor Therapeutics in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.18% less ownership

Funds ownership: 0.71% → 0.53% (-0.18%)

5% less funds holding

Funds holding: 19 → 18 (-1)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

70% less capital invested

Capital invested by funds: $2.29M → $677K (-$1.61M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
+$13.2K
2
UBS Group
UBS Group
Switzerland
+$10.5K
3
VF
Virtu Financial
New York
+$7.25K
4
Northern Trust
Northern Trust
Illinois
+$238

Top Sellers

1
Vanguard Group
Vanguard Group
Pennsylvania
-$381K
2
Brown Advisory
Brown Advisory
Maryland
-$56.5K
3
LTFS
Ladenburg Thalmann Financial Services
Florida
-$5.96K
4
PA
Perceptive Advisors
New York
-$4K
5
Bank of America
Bank of America
North Carolina
-$659
Name Holding Trade Value Shares
Change 		Change in
Stake
Brown Advisory
1
Brown Advisory
Maryland
$350K -$56.5K -7,109 -8%
Vanguard Group
2
Vanguard Group
Pennsylvania
$125K -$381K -47,942 -61%
CBA
3
Coastal Bridge Advisors
Connecticut
$49K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$48K – – –
AA
5
Apriem Advisors
California
$21K – – –
Northern Trust
6
Northern Trust
Illinois
$19K +$238 +30 +0.7%
BlackRock
7
BlackRock
New York
$18K -$119 -15 -0.3%
Citadel Advisors
8
Citadel Advisors
Florida
$14K +$13.2K +1,658 +101%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$10K – – –
VF
10
Virtu Financial
New York
$8K +$7.25K +913 +82%
UBS Group
11
UBS Group
Switzerland
$6K +$10.5K +1,323 +1,863%
HIIFS
12
Harel Insurance Investments & Financial Services
Israel
$3K – – –
Bank of America
13
Bank of America
North Carolina
$2K -$659 -83 -13%
LTFS
14
Ladenburg Thalmann Financial Services
Florida
$1K -$5.96K -750 -74%
AG
15
Advisor Group
Arizona
$1K – – –
CFN
16
Cordasco Financial Network
Florida
$1K – – –
FANJ
17
Financial Architects (New Jersey)
New Jersey
$1K – – –
PA
18
Perceptive Advisors
New York
– -$4K -400 Closed
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
– -$183 -23 -88%

CAPR Hedge Fund Activity: Q4 2018 in Review

18 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Capricor Therapeutics (CAPR) for Q4 2018, worth a combined $677K — down 70% from $2.29M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of CAPR and 0 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 4 added.

The largest buyer was Citadel Advisors, adding an estimated $13.2K. The largest seller was Vanguard Group, cutting an estimated $381K.

  • 18 institutional investors held Capricor Therapeutics (CAPR) as of Q4 2018, down from 19 in Q3 2018.
  • Funds reported $677K of Capricor Therapeutics stock for Q4 2018, down 70% quarter-over-quarter.
  • 0 funds opened new Capricor Therapeutics positions in Q4 2018 and 1 closed out, a net change of -1 holder.
  • The largest Capricor Therapeutics buyer in Q4 2018 was Citadel Advisors, an estimated $13.2K added.
  • The largest Capricor Therapeutics seller in Q4 2018 was Vanguard Group, an estimated $381K sold.

Based on aggregated 13F filings for Q4 2018.